"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes "
2022-06-27
عنوان الدراسة
"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes "
داعم الدراسة
Sanofi
دواء الدراسة
GLIMEPIRIDE-HOE490
رقم بروتوكول الدراسة
GLIME_R_05809
حالة الدراسة
Terminated
موقع الدراسة
KFSH
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.